387364000: Dantron (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Gastrointestinal agent (substance)\Cathartic\Laxative (substance)\Irritant cathartic (substance)\Anthraquinone laxative (substance)\Dantron

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Hydrocarbon\Aromatic hydrocarbon\Anthracene\Anthraquinone\Anthraquinone laxative (substance)\Dantron

\Ketone\Cyclic ketone\Quinone and/or quinone derivative (substance)\Quinone\Anthraquinone\Anthraquinone laxative (substance)\Dantron

\Material (substance)\Natural material\Organic natural material\Plant material\Plant product\Anthraquinone laxative (substance)\Dantron

\Biological substance\Organic natural material\Plant material\Plant product\Anthraquinone laxative (substance)\Dantron

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1481462018 Danthron en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

1492021018 Dantron en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3664918017 Dantron (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

5244201000241117 dantrone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Dantron	Is a	Anthraquinone	false	Inferred relationship	Some
Dantron	Is a	Anthraquinone laxative (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Dantron measurement	Component	True	Dantron	Inferred relationship	Some	1
Danthron poisoning	Causative agent (attribute)	True	Dantron	Inferred relationship	Some	1
Accidental danthron poisoning	Causative agent (attribute)	False	Dantron	Inferred relationship	Some
Intentional danthron poisoning	Causative agent (attribute)	False	Dantron	Inferred relationship	Some
Danthron poisoning of undetermined intent	Causative agent (attribute)	False	Dantron	Inferred relationship	Some	1
Danthron adverse reaction	Causative agent (attribute)	True	Dantron	Inferred relationship	Some	1
Allergy to dantron	Causative agent (attribute)	False	Dantron	Inferred relationship	Some
Danthron overdose	Causative agent (attribute)	True	Dantron	Inferred relationship	Some	1
Accidental danthron overdose	Causative agent (attribute)	True	Dantron	Inferred relationship	Some	1
Intentional danthron overdose	Causative agent (attribute)	True	Dantron	Inferred relationship	Some	1
Danthron overdose of undetermined intent	Causative agent (attribute)	False	Dantron	Inferred relationship	Some	1
Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dantron	Inferred relationship	Some
Dantron + poloxamer 25mg/200mg/5mL s/f oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dantron	Inferred relationship	Some
Dantron + poloxamer strong 75mg/1000mg/5mL oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dantron	Inferred relationship	Some
Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dantron	Inferred relationship	Some
Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dantron	Inferred relationship	Some
Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dantron	Inferred relationship	Some
Product containing dantron and poloxamer 188 (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dantron	Inferred relationship	Some	1
Product containing danthron and docusate sodium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dantron	Inferred relationship	Some
Product containing dantron (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dantron	Inferred relationship	Some	1
Urine danthron measurement (procedure)	Component	False	Dantron	Inferred relationship	Some	2
Accidental danthron poisoning	Causative agent (attribute)	True	Dantron	Inferred relationship	Some	1
Intentional danthron poisoning	Causative agent (attribute)	True	Dantron	Inferred relationship	Some	1
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dantron	Inferred relationship	Some
Danthron erythema (disorder)	Causative agent (attribute)	True	Dantron	Inferred relationship	Some	1
Allergy to dantron	Causative agent (attribute)	True	Dantron	Inferred relationship	Some	1
Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dantron	Inferred relationship	Some	1
Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dantron	Inferred relationship	Some	1
Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Dantron	Inferred relationship	Some	2
Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dantron	Inferred relationship	Some	1
Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Dantron	Inferred relationship	Some	1
Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dantron	Inferred relationship	Some	1
Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dantron	Inferred relationship	Some	1
Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dantron	Inferred relationship	Some	1
Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Dantron	Inferred relationship	Some	1
Dantron- and poloxamer 188-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dantron	Inferred relationship	Some	1
Product containing dantron and docusate in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dantron	Inferred relationship	Some	1
Product containing dantron and docusate (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dantron	Inferred relationship	Some	1
Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Dantron	Inferred relationship	Some	2
Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Dantron	Inferred relationship	Some	1
Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Dantron	Inferred relationship	Some	1
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dantron	Inferred relationship	Some	1
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dantron	Inferred relationship	Some	1
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dantron	Inferred relationship	Some	1
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dantron	Inferred relationship	Some	1
Product containing only dantron (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dantron	Inferred relationship	Some	1
Product containing only dantron and docusate (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dantron	Inferred relationship	Some	1
Dantron and poloxamer 188 only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dantron	Inferred relationship	Some	1
Dantron-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dantron	Inferred relationship	Some	1
Dantron and poloxamer 188 only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dantron	Inferred relationship	Some	1
Product containing only dantron and docusate in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dantron	Inferred relationship	Some	1
Dantron only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dantron	Inferred relationship	Some	1
Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dantron	Inferred relationship	Some	2
Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dantron	Inferred relationship	Some	2
Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dantron	Inferred relationship	Some	2
Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dantron	Inferred relationship	Some	2
Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dantron	Inferred relationship	Some	1
Urine danthron measurement (procedure)	Component	True	Dantron	Inferred relationship	Some	1

Reference Sets

Description inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1481462018	Danthron	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1492021018	Dantron	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3664918017	Dantron (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5244201000241117	dantrone	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module